Millions of patients die of cancer every year. There are several methods to treat cancer,
including surgery, chemotherapy, radiotherapy and immunotherapy. Recently, hyperthermia
therapy started playing a role in cancer therapy. It has shown effect in animal experiments
and clinical practice. The sponsor has developed a novel device to use hyperthermia for
advanced cancer. This study is to prove the safety in human patients of this device & therapy
and get the first data on efficacy.
Advanced Cancer, Pancreatic Cancer Metastatic
Whole body hyperthermia device,
Whole body hyperthermia device with FOLFIRINOX or FOLFOX or gemcitabine/nab-paclitaxel or gemcitabine,
Whole body hyperthermia,
Standard of Care (SOC) chemotherapy according to the NCCN guidelines.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.